Anthem Agrees to $3.63 Million Settlement Over Denied Proton Beam Radiation Cancer Treatment Coverage

If you paid out of pocket for proton beam radiation therapy to treat prostate cancer after Anthem denied your insurance coverage, you may be eligible to recover your costs under a new $3.63 million class action settlement. The lawsuit claims Anthem improperly refused to cover the advanced cancer treatment by labeling it experimental, investigational, or not medically necessary. Affected patients have until October 10, 2026, to submit a claim for financial reimbursement.

Facing a serious diagnosis like prostate cancer is overwhelming enough without your health insurance provider refusing to pay for recommended treatments. When insurance companies deny essential care, everyday people are often forced to take on massive medical debt or forego life-saving procedures altogether. At ClassActionU.org, we believe patients deserve the benefits they paid for, and we empower everyday consumers to hold large insurance corporations accountable when coverage is unfairly denied.

What Led to the Anthem Proton Beam Radiation Therapy Lawsuit?

The settlement resolves a federal class action lawsuit titled Taylor, et al. v. Blue Cross Blue Shield Healthcare Plan of Georgia Inc. and Anthem Insurance Companies Inc. (Case No. 3:23-cv-00541). The litigation was brought on behalf of patients enrolled in health benefit plans governed by the Employee Retirement Income Security Act of 1974 (ERISA).

According to the lawsuit, Anthem improperly denied coverage requests and reimbursement claims for proton beam radiation therapy aimed at treating prostate cancer. Proton beam therapy is an advanced form of radiation treatment designed to target cancer cells precisely while minimizing damage to surrounding healthy tissue and critical organs.

Plaintiffs alleged that Anthem systematically rejected coverage by classifying proton beam radiation therapy as experimental, investigational, unproven, or lacking sufficient proof of clinical effectiveness. Under federal ERISA guidelines, health plan administrators are legally required to evaluate claims fairly and in full accordance with plan terms, rather than applying arbitrary coverage denials to cut costs.

Anthem denies all allegations of wrongdoing and maintains that its coverage decisions complied with clinical criteria and applicable law. However, to avoid the rising costs, risks, and distractions of a lengthy trial, the insurer agreed to establish a $3,625,000 settlement fund to resolve the claims.

Who Is Eligible to File a Claim for Settlement Money?

You may be eligible to receive a financial payout from this settlement if you were identified by Anthem during the lawsuit’s discovery process and meet specific clinical and insurance criteria.

To qualify as an eligible class member, you must meet all of the following conditions:

• Medical Diagnosis and Treatment: You received proton beam radiation therapy specifically for the treatment of prostate cancer.

• Insurance Coverage Attempt: You requested preauthorization or submitted a claim for proton beam radiation therapy coverage through Anthem or Blue Cross Blue Shield Healthcare Plan of Georgia Inc.

• Denied Coverage: Anthem denied your preauthorization request or post-treatment claim on the grounds that the therapy was experimental, investigational, unproven, or not medically necessary under its clinical policies.

• Out-of-Pocket Expenses: No other insurance provider covered the treatment, leaving you to pay out of pocket for your medical care.

If you fulfill these conditions and Anthem identified your account during court proceedings, you can submit a paper claim form to request reimbursement for the money you spent on your care.

How Settlement Payments Will Be Calculated and Distributed

The $3,625,000 settlement fund will cover administrative costs, court-approved attorney fees of up to $906,250, legal expenses of $68,325.48, service awards of $10,000 for each of the two class representatives, and direct cash payouts to qualifying patients.

Each claimant’s payout amount will depend directly on the verifiable out-of-pocket expenses they paid for their prostate cancer treatment:

• Full Reimbursement Potential: If the total dollar amount of all approved claims is less than the net settlement fund, eligible claimants may receive up to 100 percent of their covered out-of-pocket expenses.

• Pro Rata Distribution: If total valid claims exceed the remaining fund balance, individual payments will be reduced proportionally so that every approved claimant receives a fair percentage of their out-of-pocket costs.

All payments will be distributed by physical check mailed directly to the address provided on the claimant’s completed claim form once final court approval is granted and any appeals are resolved.

Required Documentation for Submitting Your Reimbursement Claim

Unlike some consumer settlements that do not require documentation, this healthcare settlement requires proof of payment to verify your out-of-pocket losses.

To receive approval for your claim, you must submit supporting records that clearly display:

• Healthcare Provider Information: The name and full physical address of the medical facility or physician who administered the proton beam radiation therapy.

• Service Details: The exact date or range of dates when you received service, along with a description of the procedures performed.

• Proof of Payment: Official bills, itemized receipts, or financial records confirming the exact out-of-pocket amount you paid that was not covered by insurance.

Submitting complete, clear documentation with your initial claim will prevent processing delays and ensure the settlement administrator can accurately verify your payout.

Legal Rights of Patients Under Federal ERISA Regulations

Healthcare class actions involving ERISA benefit plans serve as an important safeguard for working Americans and retirees. ERISA establishes strict federal standards for employer-sponsored health insurance plans to ensure plan participants are treated fairly by insurance administrators.

Under federal law, insurance companies that manage ERISA plans owe a fiduciary duty to plan members. That means insurers must evaluate medical coverage claims using sound, updated medical evidence rather than applying blanket exclusions to lower payout costs. When an insurer improperly labels established medical procedures as experimental or unproven, affected policyholders have the right to challenge those decisions in federal court.

Class action litigation allows individual patients—who may already be facing significant medical and financial stress—to unite their claims. By joining together, consumers can effectively take on multi-billion-dollar insurance providers and recover money that should have been covered by their health plans in the first place.

Important Deadlines and Steps to Secure Your Payment

If you are an eligible class member, it is critical to follow the court’s strict schedule to ensure you receive your settlement money:

• July 27, 2026 – Exclusion Deadline: The deadline to opt out of the settlement has passed. Those who did not exclude themselves remain bound by the settlement terms and released their right to sue Anthem individually over these claims.

• August 19, 2026 – Final Approval Hearing: The court scheduled a final approval hearing to determine whether the settlement agreement is fair, reasonable, and adequate.

• October 10, 2026 – Claim Submission Deadline: This is the final day to submit your claim form.

Please note that there is currently no online claim filing option for this settlement. You must download, print, and complete the official PDF claim form and mail it along with your supporting documentation to:

Taylor, et al. v. Blue Cross Blue Shield Healthcare Plan of Georgia Inc., et al.

Settlement Administrator

P.O. Box 301132

Los Angeles, CA 90030-1132